Is a Daily Aspirin Regimen Still Recommended for Preventing a Second Heart Attack?

# Is a Daily Aspirin Regimen Still Recommended for Preventing a Second Heart Attack?

For decades, daily low-dose aspirin has been a cornerstone in the prevention of cardiovascular events, particularly for individuals who have already experienced a heart attack or stroke. This practice, known as secondary prevention, aims to reduce the risk of recurrent events by inhibiting platelet aggregation and preventing blood clot formation. However, recent updates in medical guidelines and ongoing research have led to nuanced recommendations regarding aspirin therapy. This article will explore the current understanding and recommendations for a daily aspirin regimen in preventing a second heart attack, emphasizing who benefits most and the associated risks.

Aspirin's Role in Secondary Prevention

Aspirin works by interfering with the production of thromboxane A2, a substance that promotes platelet stickiness and blood clot formation. In individuals with established atherosclerotic cardiovascular disease (ASCVD), such as those who have had a previous heart attack, stroke, or have peripheral artery disease, the benefits of daily aspirin therapy in preventing future events generally outweigh the risks. Guidelines from organizations like the American Heart Association (AHA) and the American College of Cardiology (ACC) continue to recommend low-dose aspirin (typically 75-100 mg daily, most commonly 81 mg) for secondary prevention [1].